Evaluating the Duration of Response With Mirvetuximab Soravtansine for Treating Platinum-Resistant Ovarian Cancer.

McCaw, Zachary R; Tian, Lu; Wei, Lee-Jen

McCaw, Zachary R; Tian, Lu; Wei, Lee-Jen.

Afiliação

McCaw ZR; Zachary R. McCaw, PhD, Insitro, South San Francisco, CA; Lu Tian, ScD, Department of Biomedical Data Science, Stanford University, Stanford, CA; and Lee-Jen Wei, PhD, Harvard T.H. Chan School of Public Health, Boston, MA.
Tian L; Zachary R. McCaw, PhD, Insitro, South San Francisco, CA; Lu Tian, ScD, Department of Biomedical Data Science, Stanford University, Stanford, CA; and Lee-Jen Wei, PhD, Harvard T.H. Chan School of Public Health, Boston, MA.
Wei LJ; Zachary R. McCaw, PhD, Insitro, South San Francisco, CA; Lu Tian, ScD, Department of Biomedical Data Science, Stanford University, Stanford, CA; and Lee-Jen Wei, PhD, Harvard T.H. Chan School of Public Health, Boston, MA.

J Clin Oncol ; 41(29): 4704, 2023 Oct 10.

Article em En | MEDLINE | ID: mdl-37535885

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article